DENTSPLY SIRONA Inc (NASDAQ:XRAY) was downgraded by Cleveland Research from a “buy” rating to a “neutral” rating in a report released on Thursday.

XRAY has been the topic of a number of other reports. BidaskClub cut DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 16th. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, August 14th. Credit Suisse Group reissued an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a report on Thursday, July 13th. UBS AG reissued a “neutral” rating and issued a $59.00 price target (down from $62.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $66.00 price target (down from $70.00) on shares of DENTSPLY SIRONA in a report on Thursday, August 10th. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the company. DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $65.89.

Shares of DENTSPLY SIRONA (NASDAQ XRAY) opened at 58.51 on Thursday. The stock’s market capitalization is $13.43 billion. DENTSPLY SIRONA has a one year low of $52.54 and a one year high of $65.68. The stock has a 50 day moving average of $57.21 and a 200-day moving average of $61.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.65. The company had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a negative return on equity of 54.64% and a negative net margin of 105.80%. The firm’s revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.76 EPS. Equities analysts forecast that DENTSPLY SIRONA will post $2.68 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/10/07/dentsply-sirona-inc-xray-rating-lowered-to-neutral-at-cleveland-research.html.

Several institutional investors and hedge funds have recently modified their holdings of the company. Alps Advisors Inc. raised its holdings in shares of DENTSPLY SIRONA by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after acquiring an additional 20 shares in the last quarter. Wetherby Asset Management Inc. raised its holdings in shares of DENTSPLY SIRONA by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after acquiring an additional 30 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of DENTSPLY SIRONA by 0.6% during the 1st quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock worth $424,000 after acquiring an additional 39 shares in the last quarter. BRYN MAWR TRUST Co raised its holdings in shares of DENTSPLY SIRONA by 0.5% during the 2nd quarter. BRYN MAWR TRUST Co now owns 12,064 shares of the medical instruments supplier’s stock worth $782,000 after acquiring an additional 65 shares in the last quarter. Finally, Atria Investments LLC raised its holdings in shares of DENTSPLY SIRONA by 1.5% during the 2nd quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock worth $294,000 after acquiring an additional 68 shares in the last quarter. 93.87% of the stock is currently owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related stocks with our FREE daily email newsletter.